Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6703958rdf:typepubmed:Citationlld:pubmed
pubmed-article:6703958lifeskim:mentionsumls-concept:C0019348lld:lifeskim
pubmed-article:6703958lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:6703958lifeskim:mentionsumls-concept:C0001367lld:lifeskim
pubmed-article:6703958lifeskim:mentionsumls-concept:C0014898lld:lifeskim
pubmed-article:6703958lifeskim:mentionsumls-concept:C0332237lld:lifeskim
pubmed-article:6703958lifeskim:mentionsumls-concept:C1522168lld:lifeskim
pubmed-article:6703958lifeskim:mentionsumls-concept:C1517004lld:lifeskim
pubmed-article:6703958pubmed:issue1lld:pubmed
pubmed-article:6703958pubmed:dateCreated1984-4-24lld:pubmed
pubmed-article:6703958pubmed:abstractText2'-O-glycylacyclovir, a water-soluble ester derivative of acyclovir, has proved efficacious in the topical treatment of epithelial and stromal herpes simplex keratitis, and iritis therewith associated, when administered as a 1% eyedrop formulation to rabbits.lld:pubmed
pubmed-article:6703958pubmed:languageenglld:pubmed
pubmed-article:6703958pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6703958pubmed:citationSubsetAIMlld:pubmed
pubmed-article:6703958pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6703958pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6703958pubmed:statusMEDLINElld:pubmed
pubmed-article:6703958pubmed:monthJanlld:pubmed
pubmed-article:6703958pubmed:issn0003-9950lld:pubmed
pubmed-article:6703958pubmed:authorpubmed-author:MissottenLLlld:pubmed
pubmed-article:6703958pubmed:authorpubmed-author:MaudgalP CPClld:pubmed
pubmed-article:6703958pubmed:authorpubmed-author:DescampsJJlld:pubmed
pubmed-article:6703958pubmed:authorpubmed-author:De ClercqKKlld:pubmed
pubmed-article:6703958pubmed:issnTypePrintlld:pubmed
pubmed-article:6703958pubmed:volume102lld:pubmed
pubmed-article:6703958pubmed:ownerNLMlld:pubmed
pubmed-article:6703958pubmed:authorsCompleteYlld:pubmed
pubmed-article:6703958pubmed:pagination140-2lld:pubmed
pubmed-article:6703958pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:6703958pubmed:meshHeadingpubmed-meshheading:6703958-...lld:pubmed
pubmed-article:6703958pubmed:meshHeadingpubmed-meshheading:6703958-...lld:pubmed
pubmed-article:6703958pubmed:meshHeadingpubmed-meshheading:6703958-...lld:pubmed
pubmed-article:6703958pubmed:meshHeadingpubmed-meshheading:6703958-...lld:pubmed
pubmed-article:6703958pubmed:meshHeadingpubmed-meshheading:6703958-...lld:pubmed
pubmed-article:6703958pubmed:meshHeadingpubmed-meshheading:6703958-...lld:pubmed
pubmed-article:6703958pubmed:meshHeadingpubmed-meshheading:6703958-...lld:pubmed
pubmed-article:6703958pubmed:year1984lld:pubmed
pubmed-article:6703958pubmed:articleTitleTopical treatment of experimental herpes simplex keratouveitis with 2'-O-glycylacyclovir. A water-soluble ester of acyclovir.lld:pubmed
pubmed-article:6703958pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6703958pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6703958lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6703958lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6703958lld:pubmed